x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
o |
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE
ACT
|
Date
|
Class
|
Shares
Outstanding
|
May
10, 2007
|
Common
Stock
|
249,974,695
|
BRAVO!
BRANDS INC. AND SUBSIDIARY
|
||||
TABLE
OF CONTENTS
|
||||
PART
I. FINANCIAL INFORMATION
|
||||
Item
|
1.
Financial statements
|
|||
Consolidated
balance sheets as of
|
F-1
to F-2
|
|||
March
31, 2007 (unaudited) and December 31, 2006
|
||||
Consolidated
statements of operations and comprehensive
|
F-3
|
|||
loss
for the three months
|
||||
ended
March 31, 2007 and 2006 (unaudited)
|
||||
Consolidated
statements of cash flows
|
F-4
|
|||
for
the three months ended
|
||||
March
31, 2007 and 2006 (unaudited)
|
||||
Notes
to consolidated financial statements (unaudited)
|
F-5
to F-31
|
|||
Item
|
2.
Management's Discussion and Analysis of Financial
|
32
to 43
|
||
Condition
and Results of Operations
|
||||
Item
|
3.
|
|
Controls
and Procedures
|
44
to 45
|
PART
II - OTHER INFORMATION
|
||||
Item
|
2.
|
|
Unregistered
Sales of Equity and Use of Proceeds
|
45
|
Item
|
3.
|
|
Default
on Senior Securities
|
45
|
Item
|
6.
|
|
Exhibits
|
46
to 48
|
SIGNATURES
|
49
|
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
(Unaudited)
|
|||||||
Assets
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
202,333
|
$
|
3,783,562
|
|||
Accounts
receivable, net of allowances for doubtful accounts of
$140,000 at 2007 and 2006
|
855,759
|
965,733
|
|||||
Inventories,
net of allowance for slow moving and obsolete inventory of $603,514
and
$347,000, respectively
|
1,212,774
|
2,157,866
|
|||||
Prepaid
expenses
|
399,905
|
388,565
|
|||||
Total
current assets
|
2,670,771
|
7,295,726
|
|||||
Fixed
assets, net
|
1,257,966
|
1,211,556
|
|||||
Intangible
assets, net
|
213,254
|
18,537,612
|
|||||
Other
assets
|
3,454,910
|
3,332,856
|
|||||
Total
assets
|
$
|
7,596,901
|
$
|
30,377,750
|
Liabilities,
Redeemable Preferred Stock and Stockholders’
Deficit
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$
|
12,113,147
|
$
|
8,987,940
|
|||
Accrued
liabilities
|
6,509,889
|
7,014,263
|
|||||
Notes
payable
|
2,149,301
|
243,968
|
|||||
Convertible
notes payable
|
25,624,038
|
25,486,990
|
|||||
Derivative
liabilities
|
3,871,058
|
19,941,082
|
|||||
Total
current liabilities
|
50,267,433
|
61,674,243
|
|||||
Non-current
notes payable
|
53,228
|
67,500
|
|||||
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
|
(Unaudited)
|
||||||
Redeemable
preferred stock:
|
|||||||
Series
J, par value $0.001 per share, 500,000 shares designated, 8% Cumulative
Convertible Preferred Stock, stated value $10.00 per share, 200,000
shares
issued and outstanding for 2007 and 2006
|
1,807,130
|
1,561,707
|
|||||
Series
K, par value $0.001 per share, 500,000 shares designated, 8% Cumulative
Convertible Preferred Stock, stated value $10.00 per share, 95,000
shares
issued and outstanding for 2007 and 2006
|
849,484
|
837,769
|
|||||
Total
redeemable preferred stock
|
2,656,614
|
2,399,476
|
|||||
Stockholders’
deficit:
|
|||||||
Preferred
stock, 5,000,000 shares authorized;
|
|||||||
Series
B convertible, par value $0.001 per share, 1,260,000 shares designated,
9%
Convertible Preferred Stock, stated value $1.00 per share, 107,440
shares
issued and outstanding for 2007 and 2006
|
107,440
|
107,440
|
|||||
Series
H convertible, par value $0.001 per share, 350,000 shares designated,
7%
Cumulative Convertible Preferred Stock, stated value $10.00 per share,
53,500 shares issued and outstanding for 2007 and 2006
|
535,000
|
535,000
|
|||||
Common
stock, par value $0.001 per share, 500,000,000 shares authorized,
206,492,028 and 202,429,528 shares issued and outstanding for 2007
and
2006, respectively
|
206,492
|
202,430
|
|||||
Additional
paid-in capital
|
131,286,442
|
122,414,992
|
|||||
Common
stock subscription receivable
|
(10,000
|
)
|
(10,000
|
)
|
|||
Accumulated
deficit
|
(177,523,974
|
)
|
(157,031,836
|
)
|
|||
Translation
adjustment
|
18,226
|
18,505
|
|||||
Total
stockholders’
deficit
|
(45,380,374
|
)
|
(33,763,469
|
)
|
|||
Total
liabilities, redeemable preferred stock and
stockholders’
deficit
|
$
|
7,596,901
|
$
|
30,377,750
|
Three
Months Ended March 31,
|
|||||||
2007
|
2006
|
||||||
(Unaudited)
|
(Unaudited)
|
||||||
Revenues
|
$
|
3,152,892
|
$
|
3,561,215
|
|||
Product
costs
|
(3,184,947
|
)
|
(2,946,460
|
)
|
|||
Shipping
costs
|
(277,201
|
)
|
(393,452
|
)
|
|||
Gross
margin
|
(309,256
|
)
|
221,303
|
||||
Operating
expenses:
|
|||||||
Marketing
and advertising
|
1,512,919
|
949,964
|
|||||
Selling
|
2,253,299
|
1,893,134
|
|||||
General
and administrative
|
5,601,705
|
1,765,846
|
|||||
Impairment
loss
|
17,662,006
|
--
|
|||||
Product
development
|
84,928
|
115,963
|
|||||
27,114,857
|
|
4,724,907
|
|
||||
Loss
from operations
|
(27,424,113
|
)
|
(4,503,604
|
)
|
|||
Other
income (expenses), net:
|
|||||||
Derivative
income
|
372,774
|
4,949,188
|
|||||
Interest
income (expense), net and financing costs
|
(2,342,411
|
)
|
(36,364
|
)
|
|||
Liquidated
damages
|
--
|
(685,887
|
)
|
||||
(1,969,637
|
)
|
4,226,937
|
|||||
Loss
before income taxes
|
(29,393,750
|
)
|
(276,667
|
)
|
|||
Provision
for income taxes
|
--
|
--
|
|||||
Net
loss
|
(29,393,750
|
)
|
(276,667
|
)
|
|||
Adjustments
to net loss to arrive at loss applicable to common
stockholders:
|
|||||||
Preferred
stock dividends and accretion
|
(326,948
|
)
|
(258,783
|
)
|
|||
Loss
applicable to common stockholders
|
$
|
(29,720,698
|
)
|
$
|
(535,450
|
)
|
|
Basic
and diluted loss per common share
|
$
|
(0.15
|
)
|
$
|
(0.00
|
)
|
|
Weighted
average common shares outstanding
|
203,509,389
|
184,253,753
|
|||||
Comprehensive
loss and its components consist of the following:
|
|||||||
Net
loss
|
$
|
(29,393,750
|
)
|
$
|
(276,667
|
)
|
|
Foreign
currency translation
|
(279
|
)
|
(690
|
)
|
|||
Comprehensive
loss
|
$
|
(29,394,029
|
)
|
$
|
(277,357
|
)
|
Three
Months Ended March 31
|
|||||||
2007
|
2006
|
||||||
(Unaudited)
|
(Unaudited)
|
||||||
Cash
Flows from Operating Activities:
|
|||||||
Net
(loss)
|
$
|
(29,393,750
|
)
|
$
|
(276,667
|
)
|
|
Adjustments
to net loss:
|
|||||||
Depreciation
and amortization
|
796,326
|
896,505
|
|||||
Impairment
charge
|
17,662,006
|
--
|
|||||
Bad
debt expense
|
--
|
14,941
|
|||||
Inventory
obsolescence
|
256,514
|
--
|
|||||
Derivative
income
|
(372,774
|
)
|
(4,949,188
|
)
|
|||
Amortization
of debt discount
|
1,363,825
|
11,076
|
|||||
Stock
option expense for consultants
|
--
|
347,566
|
|||||
Stock
compensation expense
|
495,622
|
111,592
|
|||||
Loss
on disposal of fixed assets
|
--
|
1,999
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable
|
109,973
|
1,596,042
|
|||||
Inventories
|
688,578
|
(2,652,769
|
)
|
||||
Prepaid
expenses and other assets
|
(9,816
|
)
|
(980,325
|
)
|
|||
Accounts
payable and accrued expenses
|
2,620,832
|
1,668,557
|
|||||
Net
cash used in operating activities
|
(5,782,664
|
)
|
(4,210,671
|
)
|
|||
Cash
Flows from Investing Activities:
|
|||||||
Licenses,
finance and trademark costs
|
--
|
(163,536
|
)
|
||||
Purchases
of equipment
|
(97,319
|
)
|
(249,910
|
)
|
|||
Net
cash used in investing activities
|
(97,319
|
)
|
(413,446
|
)
|
|||
Cash
Flows provided by Financing Activities:
|
|||||||
Proceeds
from conversion of warrants
|
--
|
150,000
|
|||||
Proceeds
from convertible notes payable
|
--
|
169,323
|
|||||
Proceeds
from notes payable
|
2,625,000
|
--
|
|||||
Payment
of dividends
|
(22,500
|
)
|
(11,257
|
)
|
|||
Payment
of notes payable
|
(13,928
|
)
|
(4,317
|
)
|
|||
Registration
costs for financing
|
(289,539
|
)
|
(17,143
|
)
|
|||
Net
cash provided by financing activities
|
2,299,033
|
286,606
|
|||||
Effect
of changes in exchange rates on cash
|
(279
|
)
|
(690
|
)
|
|||
Net
(decrease) in cash and cash equivalents
|
(3,581,229
|
)
|
(4,338,201
|
)
|
|||
Cash
and cash equivalent, beginning of period
|
3,783,562
|
4,947,986
|
|||||
Cash
and cash equivalent, end of period
|
$
|
202,333
|
$
|
609,785
|
Supplemental Cash Flow Information |
Three
Months Ended March 31,
|
||||||
2007
|
2006
|
||||||
Non-cash
investing and financing activities:
|
|||||||
Conversion
of notes payable
|
$ | 991,009 | $ |
--
|
- |
Estimating
the fair value of the Company’s financial instruments that are required to
be carried at fair value.
|
- |
Estimating
the recoverability of the Company’s long-lived assets.
|
- |
Estimating
the Company’s reserve for unsalable and obsolete inventories that are
carried at lower of cost or market.
|
Derivative
income (expense):
|
2007
|
2006
|
|||||
Convertible
note and warrant financings
|
$
|
(42,037
|
)
|
$
|
(50,904
|
)
|
|
Preferred
stock and warrant financings
|
407,152
|
1,331,015
|
|||||
Other
warrants and derivative contracts
|
7,659
|
3,669,077
|
|||||
Total
Derivative Income
|
$
|
372,774
|
$
|
4,949,188
|
Financing
or other contractual arrangement:
|
Note
|
Conversion
Features
|
Warrants
|
Total
|
June
2004 $600,000 Convertible Note Financing
|
6(a)
|
3,075,000
|
-
|
3,
075,000
|
May
2006 $2,500,000 Note Financing
|
10(c)
|
-
|
900,000
|
900,000
|
Series
J Convertible Preferred Stock
|
8(b)
|
28,000,000
|
-
|
28,000,000
|
Total
Common Shares Indexed
|
31,075,000
|
900,000
|
31,975,000
|
2007
|
2006
|
||||||
CCE
Distribution Agreement
|
$
|
--
|
$
|
15,960,531
|
|||
Manufacturing
Agreement - Jasper
|
0
|
2,700,000
|
|||||
Manufacturing
Agreement - H.P. Hood
|
0
|
2,384,055
|
|||||
Licensing
Agreement - Organic Valley
|
104,299
|
104,299
|
|||||
Trademark
costs and other licenses
|
232,916
|
237,916
|
|||||
Less
accumulated amortization
|
(123,961
|
)
|
(2,849,189
|
)
|
|||
Total
Intangible Assets
|
$
|
213,254
|
$
|
18,537,612
|
2007
|
2006
|
||||||
Production
processor liability (a)
|
$
|
2,307,418
|
$
|
850,628
|
|||
Accrued
payroll and related taxes
|
529,761
|
542,741
|
|||||
Accrued
interest
|
1,211,225
|
893,706
|
|||||
Liquidated
damages due to late registration (b)
|
1,725,607
|
3,397,419
|
|||||
Radio
advertising and promotion costs
|
--
|
716,944
|
|||||
Other
(c)
|
735,878
|
612,825
|
|||||
Total
Accrued Liabilities
|
$
|
6,509,889
|
$
|
7,014,263
|
2007
|
2006
|
||||||
International
Paper Note Payable (a)
|
$
|
187,743
|
$
|
187,743
|
|||
Notes
Payable to GMAC (b)
|
109,797
|
123,725
|
|||||
February
2007 Short Term Financing (c)
|
1,438,438
|
0
|
|||||
March
2007 Short Term Financing (d)
|
466,551
|
0
|
|||||
Total
notes payable
|
2,202,529
|
311,468
|
|||||
Less
current maturities
|
2,149,301
|
243,968
|
|||||
Long-term
notes payable
|
$
|
53,228
|
$
|
67,500
|
2007
|
2006
|
||||||
$600,000
Convertible Note Payable, due December 2005 (a)
|
$
|
450,000
|
$
|
450,000
|
|||
$30,000,000
Convertible Note Payable, due July 31, 2010 (b)
|
25,174,038
|
25,036,990
|
|||||
Total
Convertible Notes Payable
|
$
|
25,624,038
|
$
|
25,486,990
|
Derivative
income (expense)
|
Three
months ended
March
31,
2007
|
Three
months ended
March
31,
2006
|
|||||
Compound
derivative
|
$
|
(42,037
|
)
|
$
|
(132,500
|
)
|
Note
|
2007
|
2006
|
|
Compound
derivative financial instruments that have been bifurcated from the
following financing arrangements:
|
|||
$
600,000 Convertible Note Financing
|
6(a)
|
$496,304
|
$
454,267
|
$30,000,000
Convertible Note Financing
|
6(b)
|
-
|
9,326,007
|
Series
J Preferred Stock Financing
|
8(b)
|
3,108,000
|
3,416,000
|
Series
K Preferred Stock Financing
|
8(c)
|
40,413
|
139,565
|
Freestanding
derivative contracts arising from financing and other business
arrangements:
|
|||
Warrants
issued with $2,500,000 Note Financing
|
10(c)
|
226,341
|
234,000
|
Warrants
issued with $30,000,000 Convertible Notes
|
6(b)
|
-
|
6,371,243
|
Total
derivative liabilities
|
$
3,871,058
|
$
19,941,082
|
Derivative
income (expense)
|
Three
months ended
March
31,
2007
|
Three
months ended
March
31,
2006
|
|||||
Default
Put
|
$
|
0
|
$
|
(14,985
|
)
|
||
Warrant
derivative
|
$
|
0
|
$
|
327,903
|
Three
months ended
March
31,
2007
|
Three
months ended
March
31,
2006
|
||||||
Cumulative
dividends at 7%
|
$
|
35,100
|
$
|
35,100
|
|||
Accretions
|
$
|
0
|
$
|
39,174
|
Derivative
income (expense)
|
Three
months ended
March
31,
2007
|
Three
months ended
March
31,
2006
|
|||||
Compound
derivative
|
$
|
308,000
|
$
|
924,000
|
Three
months ended
March
31,
2007
|
Three
months ended
March
31,
2006
|
||||||
Cumulative
dividends at 8%
|
$
|
40,000
|
$
|
40,000
|
|||
Accretions
|
$
|
245,423
|
$
|
136,885
|
Derivative
income (expense)
|
Three
months ended
March
31,
2007
|
Three
months ended
March
31,
2006
|
|||||
Compound
derivative
|
$
|
99,152
|
$
|
(3,138
|
)
|
Three
months ended
March
31,
2007
|
Three
months ended
March
31,
2006
|
||||||
Cumulative
dividends at 8%
|
$
|
19,000
|
$
|
19,000
|
|||
Accretions
|
$
|
11,715
|
$
|
11,015
|
Derivative
income (expense)
|
Three
months ended
March
31,
2007
|
Three
months ended
March
31,
2006
|
|||||
Compound
derivative
|
$
|
0
|
$
|
5,303
|
|||
Warrant
derivative
|
$
|
0
|
$
|
91,932
|
First
|
First
|
||||||
Quarter
|
Quarter
|
||||||
2007
|
2006*
|
||||||
Expected
Term (in years)
|
6
|
n/a
|
|||||
Risk-free
rate
|
4.56
|
%
|
n/a
|
||||
Expected
volatility
|
116
|
%
|
n/a
|
||||
Expected
dividends
|
0
|
%
|
n/a
|
||||
*
No options were granted during this period.
|
Weighted-
|
|||||||||||||
Average
|
|||||||||||||
Weighted-
|
Remaining
|
||||||||||||
Average
|
Contractual
|
Aggregate
|
|||||||||||
Exercise
|
Term
|
Intrinsic
|
|||||||||||
Options
|
Shares
|
Price
|
(in
years)
|
Value
|
|||||||||
Outstanding
at December 31, 2006
|
9,403,755
|
$
|
0.31
|
||||||||||
Granted
|
25,976,724
|
$
|
0.33
|
||||||||||
Exercised
|
-
|
-
|
|||||||||||
Forfeited
|
-
|
-
|
|||||||||||
Expired
|
-
|
-
|
|||||||||||
Outstanding
at March 31, 2007
|
35,380,479
|
$
|
0.33
|
9.24
|
$
|
392,169
|
|||||||
Vested
or expected to vest at March 31 2007
|
34,218,360
|
$
|
0.33
|
9.24
|
$
|
385,446
|
|||||||
Exercisable
at March 31 , 2007
|
15,404,766
|
$
|
0.33
|
8.98
|
$
|
261,963
|
Warrants
|
Grant
date
|
Expiration
date
|
Warrants/
Options Granted
|
Exercise
Price
|
|||||||||
|
|
|
|
|
|||||||||
Warrant
to Licensor
|
6/20/2005
|
6/19/2007
|
500,000
|
0.050
|
|||||||||
Warrant
to Consultant
|
4/8/2005
|
4/7/2007
|
1,000,000
|
0.250
|
|||||||||
Warrant
to Distributor
|
8/30/2005
|
8/29/2008
|
30,000,000
|
0.360
|
|||||||||
November
2005 Bridge Loan
|
11/14/2005
|
11/13/2010
|
150,000
|
0.710
|
|||||||||
November
2005 Common Stock Financing
|
11/28/2005
|
11/27/2010
|
40,749,991
|
0.320
|
|||||||||
May
2006 Financing
|
5/12/2006
|
5/11/2011
|
900,000
|
0.320
|
|||||||||
July
2006 Convertible Note Financing
|
7/27/2006
|
7/26/2011
|
27,605,040
|
0.340
|
|||||||||
July
2006 Convertible Note - Transfer Agent
|
7/27/2006
|
7/26/2011
|
1,793,067
|
0.340
|
|||||||||
Warrant
to Processor
|
9/19/2006
|
9/18/2012
|
5,870,000
|
0.730
|
|||||||||
Warrant
to Licensor
|
10/25/2006
|
10/24/2011
|
300,000
|
0.800
|
|||||||||
February
2007 Financing
|
2/14/2007
|
2/13/2012
|
2,000,000
|
0.340
|
|||||||||
March
2007 Financing
|
3/15/2007
|
3/14/2012
|
625,000
|
0.340
|
|||||||||
Total
Warrants
|
111,493,098
|
Derivative
income (expense)
|
Three
months ended
March
31, 2007
|
Three
months ended
March
31, 2006
|
|||||
Warrant
derivative
|
$
|
7,659
|
$
|
3,669,077
|
Amount
|
||||
Nine
months ending December 31, 2007
|
$
|
121,070
|
||
Years
ending December 31,
|
||||
2008
|
$
|
161,426
|
||
2009
|
$
|
161,426
|
||
2010
|
$
|
161,426
|
||
2011
|
$
|
161,426
|
||
2012
|
$
|
161,426
|
Licensor
|
Remaining
Term
|
Aggregate
Remaining Guarantee
|
|||||
Masterfoods-
USA
|
Six
years
|
$
|
12,150,000
|
||||
Masterfoods-
Canada
|
Six
years
|
$
|
1,287,810
|
||||
Masterfoods-
Mexico
|
Six
years
|
$
|
772,700
|
||||
Diabetes
Research Institute
|
Seven
months
|
$
|
17,000
|
||||
General
Mills
|
Five
years
|
$
|
600,000
|
- |
Estimating
the fair value of our complex derivative financial instruments that
are
required to be carried as liabilities at fair value pursuant to Statements
on Financial Accounting Standards No. 133 Accounting
for Derivative Financial Instruments and Hedging Activities (FAS
133)
|
- |
Estimating
the future recoverability of our long-lived assets, consisting of
property
and equipment and intangible assets, pursuant to Statements on Financial
Accounting Standards No. 144 Accounting
for the Impairment or Disposal of Long-lived Assets (FAS
144)
|
- |
Estimating
the Company’s reserve for unsalable and obsolete inventories that are
carried at lower of cost or market.
|
2007
|
2006
|
$
Change
|
%
Change
|
||||||||||
Revenues
|
$
|
3,152,892
|
$
|
3,561,215
|
$
|
(408,323
|
)
|
(11.5
|
)%
|
2007
|
%
of Revenues
|
2006
|
%
of Revenues
|
$
Change
|
%
Change
|
||||||||||||||
Product
costs
|
$
|
3,184,947
|
101.0
|
%
|
$
|
2,946,460
|
82.7
|
%
|
$
|
238,487
|
8.1
|
%
|
|||||||
Shipping
costs
|
277,201
|
8.8
|
%
|
393,452
|
11.0
|
%
|
(116,251
|
)
|
(29.5
|
)%
|
|||||||||
Total
|
$
|
3,462,148
|
109.8
|
%
|
$
|
3,339,912
|
93.8
|
%
|
$
|
122,236
|
3.7
|
%
|
|||||||
Gross
Margin
|
(309,256
|
)
|
221,303
|
(530,559
|
)
|
(239.7
|
)%
|
||||||||||||
Margin
%
|
(9.8
|
)%
|
6.2
|
%
|
2007
|
%
of Revenues
|
2006
|
%
of Revenues
|
$
Change
|
%
Change
|
||||||||||||||
Marketing
and Advertising
|
$
|
1,512,919
|
48.0
|
%
|
$
|
949,964
|
26.7
|
%
|
$
|
562,955
|
59.3
|
%
|
|||||||
Selling
|
2,253,299
|
71.5
|
%
|
1,893,134
|
53.2
|
%
|
360,165
|
19.0
|
%
|
||||||||||
General
and administrative
|
5,601,705
|
177.7
|
%
|
1,765,846
|
49.6
|
%
|
3,835,859
|
217.2
|
%
|
||||||||||
Impairment
loss
|
17,662,006
|
560.2
|
%
|
--
|
0.0
|
%
|
17,662,006
|
100.0
|
%
|
||||||||||
Product
development
|
84,928
|
2.7
|
%
|
115,963
|
3.3
|
%
|
(31,035
|
)
|
(26.8
|
)%
|
|||||||||
Total
|
$
|
27,114,857
|
860.0
|
%
|
$
|
4,724,907
|
132.7
|
%
|
$
|
22,389,950
|
473.9
|
%
|
2007
|
%
of Revenues
|
2006
|
%
of Revenues
|
$
Change
|
%
Change
|
||||||||||||||
Derivative
income (expense)
|
$
|
372,774
|
11.8
|
%
|
$
|
4,949,188
|
139.0
|
%
|
$
|
(4,576,414
|
)
|
(92.5
|
)%
|
||||||
Interest
expense
|
(2,342,411
|
)
|
74.3
|
%
|
(36,364
|
)
|
1.0
|
%
|
(2,306,047
|
)
|
6,341.6
|
%
|
|||||||
Liquidated
damages
|
--
|
0.0
|
%
|
(685,887
|
)
|
19.3
|
%
|
685,887
|
(100.0
|
)%
|
|||||||||
Total
|
$
|
(1,969,637
|
)
|
62.5
|
%
|
$
|
4,226,937
|
118.7
|
%
|
$
|
(6,196,574
|
)
|
(146.6
|
)%
|
Cash
provided by (used in):
|
Quarter
Ended
March
31, 2007
|
Quarter
Ended
March
31, 2006
|
$
Change
|
%
Change
|
|||||||||
Operating
activities
|
$
|
(5,782,664
|
)
|
$
|
(4,210,671
|
)
|
$
|
(1,571,993
|
)
|
(37.3
|
)%
|
||
Investing
activities
|
(97,319
|
)
|
(413,446
|
)
|
316,127
|
76.5
|
%
|
||||||
Financing
activities
|
2,299,033
|
286,606
|
2,012,427
|
702.2
|
%
|
· |
ensure
information required to be disclosed by us is recorded, processed,
summarized and reported within the time periods specified in Securities
and Exchange Commission rules, regulations, and forms, and
|
· |
ensure
that such information is accumulated and communicated to our management,
including our President and Vice President- Treasurer, as appropriate,
to
allow timely and appropriate decisions regarding required disclosure
to be
made.
|
· |
inadequate
controls existed over the process for the identification and
implementation of the proper accounting for complex and non-routine
transactions
|
· |
inappropriate
accounting for compound derivative instruments embedded within our
financial instruments
|
· |
Hired
two additional full-time experienced accountants, whose key
responsibilities include creating a sound internal control structure
over
the financial reporting function
|
· |
Restructured
departmental responsibilities to properly align financial reporting
responsibilities to the employees most experienced in this
area
|
· |
Engaged
an external CPA firm with extensive experience in accounting for
complex
derivative instruments to assist us in properly accounting and reporting
of our financial instruments
|
· |
Commenced
a project to significantly improve overall internal controls. This
plan
includes the implementation of a new accounting information system
and
hiring of consultants experienced in implementing effective internal
controls, inclusive of financial reporting for compound derivative
instruments embedded within our financial
instruments.
|
Exhibit
No.
|
Document
Description
|
Incorporated
by Reference
|
Filed
Herewith
|
3.1
|
Articles
of Incorporation
|
(1)
|
|
3.2
|
Amended
Articles (name change)
|
(1)
|
|
3.4
|
Restated
Bylaws
|
(1)
|
|
4
|
Rights
of Equity Holders
|
||
4.1
|
Preferred,
Series B Designation
|
(1)
|
|
4.2
|
Preferred,
Series F Designation
|
(2)
|
|
4.3
|
Preferred,
Series G Designation
|
(3)
|
|
4.4
|
Preferred,
Series H Designation
|
(4)
|
|
4.5
|
Preferred,
Series I Designation
|
(5)
|
|
4.6
|
Preferred,
Series J Designation
|
(6)
|
|
4.7
|
Preferred,
Series K Designation
|
(8)
|
|
4.8
|
Subscription
Agreement dated November 2003 entered with Gamma Opportunity Capital
Partners, LP
|
(9)
|
|
4.9
|
Class
A Common Stock Purchase Warrant issued to Gamma Opportunity Capital
Partners, LP
|
(9)
|
|
4.10
|
Class
B Common Stock Purchase Warrant issued to Gamma Opportunity Capital
Partners, LP
|
(9)
|
|
4.11
|
Convertible
Note issued to Gamma Opportunity Capital Partners, LP dated November
2003
|
(9)
|
|
4.12
|
Class
A Common Stock Purchase Warrant issued to Libra Finance,
S.A.
|
(9)
|
|
4.13
|
Subscription
Agreement dated November 2003 entered with MID-AM CAPITAL,
L.L.C
|
(9)
|
|
4.14
|
Class
A Common Stock Purchase Warrant issued to MID-AM CAPITAL,
L.L.C.
|
(9)
|
|
4.15
|
Class
B Common Stock Purchase Warrant issued to MID-AM CAPITAL,
L.L.C
|
(9)
|
|
4.16
|
Convertible
Note issued to MID-AM CAPITAL, L.L.C. dated November 2003
|
(9)
|
|
4.17
|
Subscription
Agreement dated April 2, 2004 entered with Alpha Capital
Aktiengesellschaft and
Longview
Fund LP
|
(9)
|
|
4.18
|
Convertible
Note issued to Alpha Capital Aktiengesellschaft dated April
2004
|
(9)
|
|
4.19
|
Convertible
Note issued to Longview Fund LP dated April 2004
|
(9)
|
|
4.20
|
Common
Stock Purchase Warrant issued to Alpha Capital Aktiengesellschaft
dated
April 2004
|
(9)
|
|
4.21
|
Common
Stock Purchase Warrant issued to Longview Fund LP dated April
2004
|
(9)
|
|
4.22
|
Subscription
Agreement entered by and between the Company and Mid-AM Capital LLC
dated
June 2004
|
(10)
|
|
4.23
|
Convertible
Note issued to Mid-AM Capital LLC dated June 2004
|
(10)
|
|
4.24
|
Common
Stock Purchase Warrant A issued to Mid-AM Capital LLC dated June
2004
|
(10)
|
|
4.25
|
Common
Stock Purchase Warrant B issued to Mid-AM Capital LLC dated June
2004
|
(10)
|
4.26
|
Subscription
Agreement entered by and between the Company and Alpha Capital, Longview
Fund LP, Stonestreet Limited Partnership, Whalehaven Funds Limited
and
Gamma Opportunity Capital Partners LP dated June 2004
|
(10)
|
|
4.27
|
Form
of Common Stock Purchase A issued to Alpha Capital, Longview Fund
LP,
Stonestreet Limited Partnership, Whalehaven Funds Limited and Gamma
Opportunity Capital Partners LP dated June 2004
|
(10)
|
|
4.28
|
Form
of Common Stock Purchase B issued to Alpha Capital, Longview Fund
LP,
Stonestreet Limited Partnership, Whalehaven Funds Limited and Gamma
Opportunity Capital Partners LP dated June 2004
|
(10)
|
|
4.29
|
Form
of Convertible Note issued to Alpha Capital, Longview Fund LP, Stonestreet
Limited Partnership, Whalehaven Funds Limited and Gamma Opportunity
Capital Partners LP dated June 2004
|
(10)
|
|
4.30
|
Subscription
Agreement entered by and between the Company and Alpha Capital, Longview
Fund LP, Stonestreet Limited Partnership and Whalehaven Funds Limited
dated October 2004
|
(10)
|
|
4.31
|
Form
of Common Stock Purchase C issued to Alpha Capital, Longview Fund
LP,
Stonestreet Limited Partnership and Whalehaven Funds Limited dated
October
2004
|
(10)
|
|
4.32
|
Form
of Convertible Note issued to Alpha Capital, Longview Fund LP, Stonestreet
Limited Partnership, Whalehaven Funds Limited and Gamma Opportunity
Capital Partners LP dated October 2004
|
(10)
|
|
4.33
|
Subscription
Agreement entered by and between the Company and Momona Capital Corp.
and
Ellis International Ltd. dated December 2004
|
(10)
|
|
4.34
|
Form
of Common Stock Purchase C issued to Momona Capital Corp. and Ellis
International Ltd. dated December 2004
|
(10)
|
|
4.35
|
Form
of Convertible Note issued to Momona Capital Corp. and Ellis International
Ltd. dated December 2004
|
(10)
|
|
4.36
|
Form
of Convertible Note issued to Alpha Capital, Longview Fund LP, Longview
Equity Fund LP, Longview International Equity Fund LP and Whalehaven
Funds
Limited dated January 2005
|
(11)
|
|
4.37
|
Subscription
Agreement entered by and between the Company and Alpha Capital, Longview
Fund LP, Longview Equity Fund LP, Longview International Equity Fund
LP
and Whalehaven Funds Limited dated January 2005
|
(11)
|
|
4.38
|
Form
of Common Stock Purchase Warrant issued to Alpha Capital, Longview
Fund
LP, Longview Equity Fund LP, Longview International Equity Fund LP
and
Whalehaven Funds Limited dated January 2005
|
(11)
|
|
4.39
|
Form
of Securities Purchase Agreement with 13 institutional investors
in
connection with November 28, 2005 $20,250,000 financing
|
(12)
|
|
4.40
|
Form
of Stock Purchase Warrant in connection with November 28, 2005 $20,250,000
financing
|
(12)
|
|
10
|
Material
Contracts
|
10.6
|
MoonPie
License Agreement
|
(8)
|
|
10.7
|
Marvel
License Agreement (US)
|
(8)
|
|
10.9
|
Real
Estate Lease Amendment Extending Term
|
(8)
|
|
10.10
|
Masterfoods
License
|
(11)
|
|
10.11
|
Marvel
Enterprises License (UK)
|
(11)
|
|
10.12
|
Coca-Cola
Enterprises Master Distribution Agreement
|
(13)
|
|
16.1
|
Letter
on change or certifying accountant
|
(7)
|
|
31.1
|
Certification
of President, Rules 13a-14(a) & 15d-14(a)
|
X
|
|
31.2
|
Certification
of CAO, Rules 13a-14(a) & 15d-14(a)
|
X
|
|
32.1
|
Certifications
of President & CAO, 18 U.S.C. Sec. 1350
|
X
|
(1) |
Filed
with Form 10SB/A First Amendment
|
(2) |
Filed
with Form 10K-SB for 12-31-99
|
(3) |
Filed
with Form 10QSB for 6-30-00
|
(4) |
Filed
with Form 10K-SB 2001
|
(5) |
Filed
with Form 10QSB for 6-30-02
|
(6) |
Filed
with Form 8-K for 10-02-02
|
(7) |
Filed
with Form 8-K for 3-26-04
|
(8) |
Filed
with Form 10K-SB 2003
|
(9) |
Filed
with Form SB-2 June 4, 2004
|
(10) |
Filed
with Form SB-2 January 21, 2005
|
(11) |
Filed
with Form 10K-SB 2004
|
(12) |
Filed
with Form 8-K for 11-28-05
|
(13) |
Filed
with Form 10QSB for 9-30-05
|
Signature
|
Title
|
Date
|
||
/S/
Benjamin Patipa
|
President
|
May
15, 2007
|
||
(Principal
Executive Officer)
|
||||
/S/
Tommy E. Kee
|
Vice
President and Treasurer,
|
May
15, 2007
|
||
(Principal
Accounting Officer)
|